Financials
Financial year 2025
Laboratoires Sterop from Anderlecht, company number BE0408238752, closed financial year 2025 with a result of € -529,412 after tax. For that financial year Laboratoires Sterop recorded revenue of € 17.3 million and equity of € 8 million. Compared with financial year 2024, the result moved from € 947,384 to € -529,412. The company made a loss. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on September 23, 2026.
€ 8 million
▲ 9% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -529,412
▼ still € 947,384 profit in 2024
Profit after tax over the fiscal year.
€ 2 million
▲ € 1.7 million vs 2024
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € 3.4 million.
People and assets in 2025
101.5
▲ 10.1 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 6.4 million
▲ 13% vs 2024
€ 63,300 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 1.4 million
▲ € 1.3 million vs 2024
Of which on lease € 1.3 million.
Debts at end 2025
€ 10.5 million
▲ 247% vs 2024
€ 19,474 is repaid this year. At this pace the long-term loan is gone in ≈ 473 years.
€ 3.3 million
▼ 41% vs 2024
Supplier invoices still open on the last day of the fiscal year. Pays suppliers within 115 days on average.
€ 1.2 million
▼ 2% vs 2024
Taxes, VAT and social contributions still to pay.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Revenue | € 11,832,314 | € 15,507,574 | € 15,588,102 | € 17,345,927 | ▲ 11% |
| Profit after taxes | € 69,078 | € 988,571 | € 947,384 | € -529,412 | ▼ € 1.5 million |
| Equity | € 7,193,488 | € 7,202,059 | € 7,400,189 | € 8,032,650 | ▲ 9% |
| Total debts | € 3,685,532 | € 9,147,064 | € 11,487,129 | € 15,861,076 | ▲ 38% |
| Cash | € 496,439 | € 634,247 | € 337,597 | € 2,037,902 | ▲ € 1.7 million |
| Land & buildings | € 1,284,059 | € 3,933,616 | € 3,731,385 | € 4,927,555 | ▲ 32% |
| Retained profit | € 3,093,488 | € 3,102,059 | € 3,109,443 | € 3,414,417 | ▲ 10% |
| Dividend | € 0 | € 980,000 | € 940,000 | € 375,000 | ▼ 60% |
| Bank debt | € 93,100 | € 3,397,537 | € 3,019,966 | € 10,476,661 | ▲ 247% |
| Balance sheet total | € 10,879,020 | € 16,349,123 | € 18,887,317 | € 23,929,726 | ▲ 27% |
| Employees (FTE) | 81.4 | 90.1 | 91.4 | 101.5 | ▲ 10.1 |
Key figures of Laboratoires Sterop, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to Laboratoires Sterop?
What happened at Laboratoires Sterop in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Daniel CATOUL stepped down as director. NBB
- E3A PARTNERS SRL stepped down as director. NBB
- New annual accounts for financial year 2025: loss of € 529,412 (▼ € 1.5 million vs 2024). filed late Source: NBB ↗
- New establishment in Anderlecht. KBO
- Rita LABIS stepped down as director. NBB
- Daniel CATOUL became a director. NBB
- E3A PARTNERS SRL became a director. NBB
- Rita LABIS became a director. NBB
In short
From € 69,078 profit in 2022 to € 529,412 loss in 2025.
Paid € 944,799 in corporate taxes since 2022.
Best year ever: 2023, with € 988,571 profit.
Paid out € 2.3 million in dividends to the owners in total.
Management
The stake of PHARMASOVA comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
Laboratoires SteropThe shares are held by PHARMASOVA (100%).
Directors
According to the 2025 annual accounts
since 2017 · until 2023
Daniel CATOUL
Director
Also active at: Laboratoires Belges Pharmacobel, Etablissements Medi-Labo, C.D. & ASSOCIES, Leo Keller en Zonen, T.DIFFUSION, Sterop Overseas, ALTERNATIV WORKSPACE SOLUTIONS, S.A. Laboratoires Pharmaceutiques Trenker +7 more
since 2021 · until 2027
Managing director · represented by Sophie EYKERMAN
Also active at: Laboratoires Belges Pharmacobel, Etablissements Medi-Labo, Sterop Overseas, PHARMASOVA
since 2021 · until 2027
Shareholders
100%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Scheutlaan 46-50
1070 Anderlecht
Scheutlaan 46 50
1070 Anderlecht
Active since 1 January 1971
Scheutlaan 194
1070 Anderlecht
Active since 1 June 2017
Researchdreef 20
1070 Anderlecht
Active since 15 December 2023
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Website
Technologies
Hosting & Email
Email provider
Barracuda
Hosting
CLOUDFLARENET - Cloudflare, Inc., US
DNS
Cloudflare DNS
Domain
Domain
sterop.be
Registered
2001-05-09
Website info
Features
Security
Network
Details
- Company number
- 0408.238.752
- VAT number
- BE 0408.238.752
- Registered office
- Scheutlaan 46-50, 1070 Anderlecht
- Names & denominations
- Laboratoires Sterop
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 1 January 1971
- Peppol
- Active · Active since 12 Feb 2026
- Contact
- sterop.be +32 2 524 39 66
- Activities · NACE
Vervaardiging van geneesmiddelen
Vervaardiging van overige chemische producten
Vervaardiging van andere chemische producten, neg